Literature DB >> 19290795

CYP3A5 and ABCB1 genes and hypertension.

Murielle Bochud1, Pascal Bovet, Michel Burnier, Chin B Eap.   

Abstract

Hypertension is the first single modifiable cause of disease burden worldwide. Genes encoding proteins that are involved in the metabolism (CYP3A5) and transport (ABCB1) of drugs and hormones might contribute to blood pressure control in humans. Indeed, recent data have suggested that CYP3A5 and ABCB1 gene polymorphisms are associated with blood pressure in the rat as well as in humans. Interestingly, the effects of these genes on blood pressure appear to be modified by dietary salt intake. This review summarizes what is known regarding the relationships of the ABCB1 and CYP3A5 genes with blood pressure, and discusses the potential underlying mechanisms of the association. If the role of these genes in blood pressure control is confirmed in other populations and other ethnic groups, these findings would point toward a new pathway for blood pressure control in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19290795     DOI: 10.2217/14622416.10.3.477

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  13 in total

1.  PharmGKB summary: very important pharmacogene information for CYP3A5.

Authors:  Jatinder Lamba; Joan M Hebert; Erin G Schuetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-07       Impact factor: 2.089

Review 2.  The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

Authors:  Dennis A Hesselink; Rachida Bouamar; Laure Elens; Ron H N van Schaik; Teun van Gelder
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

3.  Association Between ABCB1 Gene Polymorphism and Renal Function in Patients with Hypertension: A Case-Control Study.

Authors:  Xiaofang Chen; Tao Zhou; Deguang Yang; Jinyang Lu
Journal:  Med Sci Monit       Date:  2017-08-09

4.  Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.

Authors:  Murielle Bochud; Michel Burnier; Idris Guessous
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12

5.  Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.

Authors:  Ripudaman K Bains; Mirna Kovacevic; Christopher A Plaster; Ayele Tarekegn; Endashaw Bekele; Neil N Bradman; Mark G Thomas
Journal:  BMC Genet       Date:  2013-05-03       Impact factor: 2.797

6.  Association between ABCB1 Polymorphisms and Ischemic Stroke in Korean Population.

Authors:  Young-Ock Kim; Seung-Yu Kim; Dong Hwan Yun; Sang-Won Lee
Journal:  Exp Neurobiol       Date:  2012-12-26       Impact factor: 3.261

Review 7.  Developments in renal pharmacogenomics and applications in chronic kidney disease.

Authors:  Ariadna Padullés; Inés Rama; Inés Llaudó; Núria Lloberas
Journal:  Pharmgenomics Pers Med       Date:  2014-08-28

8.  Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study.

Authors:  Yassine Bouatou; Ludwig Stenz; Belen Ponte; Serge Ferrari; Ariane Paoloni-Giacobino; Karine Hadaya
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

Review 9.  Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation.

Authors:  Meng Yu; Mouze Liu; Wei Zhang; Yingzi Ming
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

Review 10.  Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini review.

Authors:  Rabia Johnson; Phiwayinkosi Dludla; Sihle Mabhida; Mongi Benjeddou; Johan Louw; Faghri February
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.